Diabetes Drug Makes Heart Attack Risk
Diabetes Drug Makes Heart Attack Risk - Based on data gathered from various research and clinical trials, diabetes drug Avandia increased the risk of heart attack. However, the Food and Drug Administration (FDA) will decide the fate of a new drug that is selling this at the next July.
The debate about the benefits and side effects Avandia has become a noisy discussion in recent time. In the meta-analysis study published in the Archives of Internal Medicine, noted that the production of GlaxoSmithKline’s drug showed no risk of death from cardiovascular disease.
Meanwhile, another study published in the Journal of the American Medical Association found that elderly patients who take Avandia have a risk of heart attack is greater than similar patients taking other brands.
In 2007, the board of the FDA experts have expressed Avandia’s increased risk of heart attack but did not ban the circulation of this drug.
Avandia was approved by the FDA in 1990 to cope with rising blood sugar in type 2 diabetics. Concerns about possible adverse effects of these drugs in heart appeared in 2007. Since then, various studies conducted to prove the existence of the risk of heart attack, but there were few studies have focused on the benefits of this drug for patients with diabetes.
Amid all the controversy that, in the year 2005, the court ordered GlaxoSmithKline to conduct clinical trials that the results announced to the public. Research and then randomized to 35 500 patients. Apparently, Avandia was shown to increase the risk of heart attack between 28 and 39 percent, but did not increase the risk of death.
